Axcellerate Pharma deploys a unique combination of assets and operational capabilities to provide high quality CRO and CDMO services. Axcellerate Pharma is ideally positioned to accommodate drug product development activities as well as the manufacture of early cGMP clinical supplies of drug substance and sterile drug product for both large and small molecules. Axcellerate’s capabilities include a full complement of organic synthesis, analytical methods development and biological services. In addition, Axcellerate Pharma has dedicated process areas for biologics development, chemical development and sterile manufacturing of drug product including lyophilization.

Serives

Our Services

Axcellerate Pharma offers expertise in the manufacture of various types of Services. Please click here to learn more about our services.

Capabilities

Our Capabilities

Axcellerate Pharma have capabilities in many areas. Please click here to learn more about our capabilities.

Alliance Partners

March 20 – 23
DCAT, NY
Learn More

March 21 – 23
Interphex, New York
Learn More

May 16 – 18
CPhI North America, Philadelphia
Learn More

June 19 – 22
BIO, San Diego
Learn More

September 14-15
Contract Pharma, NJ
Learn More

Like what you have seen?

Commercial Manufacturing | CRO/CDMO

Generics
Lyophilization
Control Substances
Hormones & Steroids
Cytotoxic, Oncology

Sterile Injectables
Vials
Syringes
Cartridges
Bags

Biologics
Mammalian Cell Culture
Microbial Fermentation
Oligonucleotides
PEGylation